Integer Holdings Corporation

NYSE:ITGR

Medical - Devices

Healthcare
$126.97 +1.29%

+$1.16 today

Market cap
$4.32B
Beta
0.65
P/E (TTM)
21.9
EPS (TTM)
$4.14
52W Low $62.00High $123.78

Volume 0.80M

Average 0.54M

ITGR EBITDA Margin

EBITDA as a percentage of revenue.

Integer Holdings CorporationNYSE: ITGR

EBITDA Margin · Q2 FY2026 · quarter ended Jul 2026

EBITDA Margin narrows to 14.6%

EBITDA Margin was 14.6% in Q2 FY2026, down 3.9 pp from a year earlier. On a trailing-twelve-month basis it was 17.0%, up 0.5 pp year over year. Over 3 fiscal years it narrowed by 0.6 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 22.9% for the fiscal year ending Dec 2026, up from 16.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
14.6%-0.2 pp QoQ
Last fiscal yearDec 2025
16.2%-3.3 pp YoY
LTMJul 2026
17.0%+0.5 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.9 pp+5.1 pp+9.0 pp
1 year-3.3 pp+6.7 pp+10.0 pp
3 years-0.6 pp+6.5 pp+7.0 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
16.2%
Year-over-year change
-3.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ITGR compares with its peers on the latest reported figures

  • ITGR's LTM Jul 2026 EBITDA Margin of 17.0% is the 4th highest of the 10 companies compared; the peer median is 14.0%.
  • Its year-over-year change of +0.5 pp is the 7th highest of 10, against a peer median of +1.3 pp.
  • Over three fiscal years its change of -0.6 pp compares with a peer median of -0.2 pp.
ITGR Competitors Peer median
EBITDA Margin for ITGR and competitors
Company Period LTM level YoY 3-year change
CONConcentra Group Holdings Parent, Inc.LTM Sep 202620.5% +1.3 pp-0.2 pp
HAEHaemonetics CorporationLTM Jun 202619.3% -8.7 pp-2.2 pp
UFPTUFP Technologies, Inc.LTM Jun 202618.4% -0.8 pp-0.5 pp
ITGRInteger Holdings CorporationLTM Jul 202617.0% +0.5 pp-0.6 pp
AORTArtivion, Inc.LTM Mar 202614.2% +5.1 pp+6.3 pp
LIVNLivaNova PLCLTM Sep 202614.0% +20.0 pp-12.4 pp
ADUSAddus HomeCare CorporationLTM Jun 202611.3% +0.7 pp+2.0 pp
INSPInspire Medical Systems, Inc.LTM Jun 20269.2% -0.9 pp+18.7 pp
PRCTPROCEPT BioRobotics CorporationLTM Mar 2026-28.6% +3.8 pp+77.8 pp
RXRXRecursion Pharmaceuticals, Inc.LTM Jun 2026-810.2% +95.5 pp-175.3 pp
Peer median (excluding ITGR) 14.0%+1.3 pp-0.2 pp

Competitors are the stored peer set for ITGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.22B1.33B1.56B1.72B1.85B
Cost of Revenue884.11M984.63M1.14B1.26B1.42B
Gross Profit336.97M346.65M411.52M461.18M425.81M
Gross Margin27.6%26.0%26.5%26.9%23.1%
Research & Development51.99M59.76M61.97M53.43M46.35M
Selling, General & Admin141.69M157.36M171.47M184.33M162.59M
Operating Expenses201.26M233.97M248.2M252.95M216.55M
Depreciation & Amortization81.37M91.99M98.84M111.03M130.67M
EBITDA224.43M222.84M277.56M334.27M298.38M
EBITDA Margin18.4%16.7%17.8%19.5%16.2%
Operating Income135.71M112.68M163.32M208.24M209.27M
Operating Margin11.1%8.5%10.5%12.1%11.3%
Interest Income00000
Interest Expense31.63M37.27M53.37M56.37M42.31M
Other Income / Expenses(34.65M)(44M)(57.94M)(60.68M)(83.87M)
Income Before Tax101.06M68.68M105.38M147.56M125.4M
Pre-Tax Margin8.3%5.2%6.8%8.6%6.8%
Income Tax Expense8.04M8.93M16.24M26.51M22.57M
Net Income96.81M66.38M90.65M119.9M102.76M
Net Margin7.9%5.0%5.8%7.0%5.6%
EPS (Basic)2.821.972.723.602.96
EPS (Diluted)2.801.962.693.402.89
Weighted Avg Shares32.99M33.13M33.32M33.6M34.74M
Weighted Avg Shares (Diluted)33.26M33.36M33.76M35.65M35.59M

Integer Holdings Corporation

NYSE:ITGR

Intrinsic Alpha fair value

Locked

Current Price

$126.97

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.